NHEJ-mediated DNA synapsis and RPA-driven MRX exonuclease balance DNA end resection to control DSB repair

November 18, 2026 – A study published in Nature Communications explores how cells balance the two main pathways for repairing DNA double-strand breaks: non-homologous end-joining (NHEJ) and homologous recombination (HR). The researchers identified how the temporary joining of broken DNA ends during NHEJ protects them from premature processing, while a specific protein helps facilitate the […]

Uncovering how autoantibodies act and team-up to broadly neutralize interferon-α

November 13, 2026 – In a study published in Immunity, researchers from the Institute for Research in Biomedicine in Bellinzona, Switzerland, together with collaborators at Zurich and Stanford University, identify human antibodies that neutralize interferon-α and show how combining them enhances their ability to block this key antiviral factor. Interferon-α (IFN-α) is a protein produced […]

IRB Researcher Veronica Martini Awarded a BRIDGE Proof of Concept Grant

Veronica Martini, a researcher at the Institute for Research in Biomedicine (IRB) in Bellinzona, affiliated with Università della Svizzera italiana (USI), has received a BRIDGE Proof of Concept grant to advance the development of a new class of CXCR2 inhibitors. The project explores an innovative strategy to target tumour-associated neutrophils and investigate new therapeutic approaches […]

Genetic variation linked to autoimmunity reveals a mechanism controlling T cell responses

October 20, 2026 – A study published in the Journal of Experimental Medicine by the lab of Silvia Monticelli at Institute for Research in Biomedicine (IRB) in Bellinzona, affiliated with USI, in collaboration with the lab of Gioacchino Natoli at IEO, reveals how genetic variants associated with autoimmune disease alter SKAP2 expression and in turn, […]

3rd International Workshop on Ankylosing Spondylitis Brings Experts to Bellinzona

On September 28-29, IRB hosted the 3rd International Workshop on Ankylosing Spondylitis, bringing together leading scientists and clinicians in Bellinzona to discuss recent advances in the understanding and treatment of spondyloarthritis. On September 28-29, 2026, the Institute for Research in Biomedicine (IRB), affiliated to Università della Svizzera italiana (USI), hosted the 3rd International Workshop on […]

Petr Cejka receives the 2026 Dick Marty Award

Prof. Petr Cejka, Group Leader at the Institute for Research in Biomedicine (IRB), affiliated with USI, has received the 2026 Dick Marty Award in recognition of his contribution to cancer research. Prof. Petr Cejka, head of the Recombination Mechanisms research group at the Institute for Research in Biomedicine (IRB), has been awarded the 2026 Dick […]

Bios⁺ Open Day: La Ricerca più vicina di quanto immagini

On Saturday, September 12, the Bellinzona Institutes of Science (Bios⁺) opened the doors to the public, offering visitors the opportunity to step inside the spaces where biomedical, cancer and translational research takes shape every day. For one day, laboratories, technology platforms and research spaces became places for exchange and dialogue between the scientific community and […]

Human PIF1 clears secondary DNA structures by coupled DNA unwinding and rewinding activities

A study published in the journal “Genes and Development” by Petr Cejka group demonstrates a novel functional mechanism of human PIF1, a multifunctional DNA helicase involved in replication and repair. Unlike classical DNA unzipping helicase’s role, hPIF1 acts as a DNA translocase coupling local unwinding with rapid rewinding to resolve complex DNA secondary structures. Human PIF1 has been assumed for a long […]

Role of Plasmacytoid Dendritic Cells in Immune Responses Following coronavirus mRNA Vaccination: a Preclinical Mouse Study

What happens in the lymph node after mRNA vaccination? In eBioMedicine, the Infection and Immunity group at IRB, led by Prof. Santiago F. González,  identifies plasmacytoid dendritic cells as contributors both to the humoral and cell mediated (CD8⁺ T-cell) responses induced by the Pfizer-BioNTech BNT162b2 vaccine. The Pfizer-BioNTech coronavirus vaccine (BNT162b2) was among the first […]

Porte Aperte Bios+: la Ricerca più vicina di quanto immagini

Dear Sir or Madam, The Institute for Research in Biomedicine (IRB), the Institute of Oncology Research (IOR), and the Institute for Translational Research (IRT) are pleased to invite you to their Open Day, which will take place on Saturday, September 12, 2026, at the Bios⁺ building in Bellinzona (Via F. Chiesa 5). The event will […]

Footer Logo